Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition-Reference-Cited by-同舟云学术

Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition

Published:2006-12-05 Issue:23 Volume:114 Page:2474-2481
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Cardinale Daniela¹,Colombo Alessandro¹,Sandri Maria T.¹,Lamantia Giuseppina¹,Colombo Nicola¹,Civelli Maurizio¹,Martinelli Giovanni¹,Veglia Fabrizio¹,Fiorentini Cesare¹,Cipolla Carlo M.¹

Affiliation:

1. From the Cardiology Unit (D.C., A.C., G.L., N.C., M.C., C.M.C.), Laboratory Medicine Unit (M.T.S.), and Haemato-Oncology Division (G.M.), European Institute of Oncology, I.R.C.C.S., and Centro Cardiologico Monzino (F.V., C.F.), I.R.C.C.S., University of Milan, Milan, Italy.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference35 articles.

1. Cancer Survivorship—Genetic Susceptibility and Second Primary Cancers: Research Strategies and Recommendations

2. Cancer prevalence in European registry areas

3. Rosenthal DS Braunwald E. Cardiac effects of radiation therapy and chemotherapy. In: Braunwald E ed. Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia Pa: WB Saunders Co; 2001: 1746–1751.

4. Cardiotoxicity of Chemotherapeutic Agents

5. Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy

Cited by 836 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anthracycline-induced cardiotoxicity: An overview from cellular structural perspective;Biomedicine & Pharmacotherapy;2024-10

2. Cardioprotection strategies for anthracycline cardiotoxicity;Basic Research in Cardiology;2024-09-09

3. High-sensitivity cardiac troponin I-guided combination angiotensin receptor blockade and beta blocker therapy to prevent anthracycline cardiotoxicity: the Cardiac CARE RCT;Efficacy and Mechanism Evaluation;2024-08

4. Preventing Cardiac Damage in Patients Treated for Breast Cancer and Lymphoma;JACC: CardioOncology;2024-08

5. Cardioprotection Using Doxorubicin: The Role of Dexrazoxane;Pharmaceutical Science;2024-07-10